| Family Service, Inc. | |
|
2210 S Brown Pl Sioux Falls SD 57105-6582 | |
| (605) 336-1974 | |
| Not Available |
| Full Name | Family Service, Inc. |
|---|---|
| Speciality | Counselor |
| Location | 2210 S Brown Pl, Sioux Falls, South Dakota |
| Authorized Official Name and Position | Deanne Renae Ludewig (BILLING ADMINISTRATOR) |
| Authorized Official Contact | 6053361974 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Service, Inc. 2210 S Brown Pl Sioux Falls SD 57105-6582 Ph: () - | Family Service, Inc. 2210 S Brown Pl Sioux Falls SD 57105-6582 Ph: (605) 336-1974 |
| NPI Number | 1003961145 |
|---|---|
| Provider Enumeration Date | 01/25/2007 |
| Last Update Date | 05/28/2021 |
| Certification Date | 05/28/2021 |
| Medicare PECOS PAC ID | 9739071192 |
|---|---|
| Medicare Enrollment ID | O20040329001292 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003961145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Ruth A Kaspar |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164527487 PECOS PAC ID: 3375532260 Enrollment ID: I20040506001536 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Jeanne Carol Carlsen |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1609956283 PECOS PAC ID: 2769440114 Enrollment ID: I20041230000771 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Shelley L Sandbulte |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1871587253 PECOS PAC ID: 0749299105 Enrollment ID: I20060412000388 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Todd W Herrboldt |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1144376567 PECOS PAC ID: 2163615022 Enrollment ID: I20101023000034 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Paula L Smykle |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417209420 PECOS PAC ID: 8224356217 Enrollment ID: I20150423002290 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Sarah J Shoffner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932623527 PECOS PAC ID: 6305175415 Enrollment ID: I20190913001966 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
| Provider Name | Erika J Warren |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417474701 PECOS PAC ID: 9436147956 Enrollment ID: I20210601001470 |
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
News Archive
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists have discovered a pattern in the DNA sequence of the mouse genome that may play a fundamental part in the way DNA molecules regulate gene expression.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing intravenous and topical oxygen-carrier products, today announced results for the fiscal year (FY) 2013 first quarter ended July 31, 2012.
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
› Verified 1 days ago
Sozo Counseling Care, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2701 S Minnesota Ave, Suite 3, Sioux Falls, SD 57105 Phone: 605-339-3378 Fax: 605-339-0510 | |
Abide Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6809 S Minnesota Ave Ste 102, Sioux Falls, SD 57108 Phone: 605-988-8125 Fax: 605-362-5803 | |
Wellnite Medical Group Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5013 S Louise Ave, Sioux Falls, SD 57108 Phone: 877-644-6008 | |
Lisa Reyes Social Work, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 9309 W Kingfisher Dr, Sioux Falls, SD 57107 Phone: 605-610-6307 | |
Avera Mckennan Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4400 W 69th St Ste 3100, Sioux Falls, SD 57108 Phone: 605-504-3522 Fax: 605-322-4345 | |
Avera Medical Group University Psychiatry Associates Sioux Falls Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4400 W 69th St Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 Fax: 605-322-5704 |